BR0208596A - Variante de polipeptìdeo com gama interferon (ifng), seqência de nucleotìdeos, vetor de expressão, célula hospedeira de glicosilação, população de variantes de polipeptìdeo com ifng ou de uma composição, composição farmacêutica, uso de uma variante de polipeptìdeo, e, métodos para o tratamento de doenças pulmonares intersticiais, para aumentar o grau de n-glicosilação in vivo de um polipeptìdeo com ifng parental, e para a produção de uma variante de polipeptìdeo com ifng - Google Patents
Variante de polipeptìdeo com gama interferon (ifng), seqência de nucleotìdeos, vetor de expressão, célula hospedeira de glicosilação, população de variantes de polipeptìdeo com ifng ou de uma composição, composição farmacêutica, uso de uma variante de polipeptìdeo, e, métodos para o tratamento de doenças pulmonares intersticiais, para aumentar o grau de n-glicosilação in vivo de um polipeptìdeo com ifng parental, e para a produção de uma variante de polipeptìdeo com ifngInfo
- Publication number
- BR0208596A BR0208596A BR0208596-8A BR0208596A BR0208596A BR 0208596 A BR0208596 A BR 0208596A BR 0208596 A BR0208596 A BR 0208596A BR 0208596 A BR0208596 A BR 0208596A
- Authority
- BR
- Brazil
- Prior art keywords
- ifng
- polypeptide
- glycosylation
- polypeptide variant
- variant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100579 | 2001-04-06 | ||
| DKPA200100714 | 2001-05-07 | ||
| DKPA200200198 | 2002-02-11 | ||
| PCT/DK2002/000226 WO2002081507A2 (en) | 2001-04-06 | 2002-04-04 | Interferon gamma polypeptide variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0208596A true BR0208596A (pt) | 2004-03-09 |
Family
ID=27222504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0208596-8A BR0208596A (pt) | 2001-04-06 | 2002-04-04 | Variante de polipeptìdeo com gama interferon (ifng), seqência de nucleotìdeos, vetor de expressão, célula hospedeira de glicosilação, população de variantes de polipeptìdeo com ifng ou de uma composição, composição farmacêutica, uso de uma variante de polipeptìdeo, e, métodos para o tratamento de doenças pulmonares intersticiais, para aumentar o grau de n-glicosilação in vivo de um polipeptìdeo com ifng parental, e para a produção de uma variante de polipeptìdeo com ifng |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1412382A2 (zh) |
| JP (1) | JP2005518183A (zh) |
| KR (1) | KR20030094336A (zh) |
| CN (1) | CN1257186C (zh) |
| BG (1) | BG108256A (zh) |
| BR (1) | BR0208596A (zh) |
| CA (1) | CA2443277A1 (zh) |
| HK (1) | HK1069834A1 (zh) |
| HU (1) | HUP0303645A3 (zh) |
| IL (1) | IL157896A0 (zh) |
| MX (1) | MXPA03009082A (zh) |
| NO (1) | NO20034432L (zh) |
| NZ (1) | NZ528651A (zh) |
| PL (1) | PL366705A1 (zh) |
| WO (1) | WO2002081507A2 (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2390262A1 (en) | 2003-05-16 | 2011-11-30 | Intermune, Inc. | Synthetic chemokine receptor ligands and methods of use thereof |
| JP4707327B2 (ja) * | 2004-01-27 | 2011-06-22 | 旭化成ファーマ株式会社 | ポリペプタイド類の吸着防止剤 |
| KR20070085227A (ko) * | 2004-08-09 | 2007-08-27 | 앨리오스 바이오파마 인크. | 합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법 |
| US7597884B2 (en) * | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| CN103550757A (zh) * | 2005-09-20 | 2014-02-05 | 纽约大学 | 用干扰素治疗肺病的方法 |
| US7625555B2 (en) | 2007-06-18 | 2009-12-01 | Novagen Holding Corporation | Recombinant human interferon-like proteins |
| JP5769142B2 (ja) * | 2007-09-04 | 2015-08-26 | 独立行政法人酒類総合研究所 | ピヒア属酵母において異種タンパク質を高分泌させる方法 |
| EP2039764A1 (en) * | 2007-09-19 | 2009-03-25 | Pevion Biotech AG | Truncated secretory aspartyl proteinase 2 |
| BG66517B1 (bg) | 2008-04-08 | 2016-02-29 | Tigo Gmbh | Супресор на ендогенния човешки гама - интерферон |
| RU2446821C2 (ru) * | 2010-07-15 | 2012-04-10 | Олег Ильич Эпштейн | Лекарственное средство для лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способ лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями |
| GB201621728D0 (en) | 2016-12-20 | 2017-02-01 | Ucb Biopharma Sprl | Methods |
| BG67190B1 (bg) | 2017-03-29 | 2020-11-16 | Tigo Gmbh | Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон |
| WO2023182947A1 (en) * | 2022-03-22 | 2023-09-28 | Chiang Mai University | A modified protein of interferon gamma and its use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9203641A (es) * | 1983-12-16 | 1992-07-01 | Genentech Inc | Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion. |
| BG52073B2 (en) * | 1990-01-24 | 1996-04-30 | Inst Molekuljarna Biolog | Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine |
| DE4036856C1 (zh) * | 1990-11-19 | 1992-05-27 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De |
-
2002
- 2002-04-04 CN CNB028078918A patent/CN1257186C/zh not_active Expired - Fee Related
- 2002-04-04 CA CA002443277A patent/CA2443277A1/en not_active Abandoned
- 2002-04-04 WO PCT/DK2002/000226 patent/WO2002081507A2/en active Application Filing
- 2002-04-04 HU HU0303645A patent/HUP0303645A3/hu unknown
- 2002-04-04 MX MXPA03009082A patent/MXPA03009082A/es not_active Application Discontinuation
- 2002-04-04 NZ NZ528651A patent/NZ528651A/en unknown
- 2002-04-04 EP EP02722021A patent/EP1412382A2/en not_active Withdrawn
- 2002-04-04 BR BR0208596-8A patent/BR0208596A/pt not_active IP Right Cessation
- 2002-04-04 JP JP2002579493A patent/JP2005518183A/ja active Pending
- 2002-04-04 PL PL02366705A patent/PL366705A1/xx not_active Application Discontinuation
- 2002-04-04 KR KR10-2003-7013263A patent/KR20030094336A/ko not_active Application Discontinuation
- 2002-04-04 IL IL15789602A patent/IL157896A0/xx unknown
-
2003
- 2003-10-03 NO NO20034432A patent/NO20034432L/no not_active Application Discontinuation
- 2003-10-10 BG BG108256A patent/BG108256A/bg unknown
-
2005
- 2005-03-15 HK HK05102256A patent/HK1069834A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1257186C (zh) | 2006-05-24 |
| NO20034432L (no) | 2003-10-29 |
| CA2443277A1 (en) | 2002-10-17 |
| JP2005518183A (ja) | 2005-06-23 |
| BG108256A (bg) | 2004-12-30 |
| HK1069834A1 (en) | 2005-06-03 |
| HUP0303645A3 (en) | 2005-12-28 |
| MXPA03009082A (es) | 2004-11-22 |
| WO2002081507A2 (en) | 2002-10-17 |
| PL366705A1 (en) | 2005-02-07 |
| IL157896A0 (en) | 2004-03-28 |
| NO20034432D0 (no) | 2003-10-03 |
| WO2002081507A3 (en) | 2004-02-12 |
| EP1412382A2 (en) | 2004-04-28 |
| HUP0303645A2 (hu) | 2004-01-28 |
| NZ528651A (en) | 2006-06-30 |
| CN1537117A (zh) | 2004-10-13 |
| KR20030094336A (ko) | 2003-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10383796B2 (en) | Application and uses of PRG4 and therapeutic modulation thereof | |
| BR0208596A (pt) | Variante de polipeptìdeo com gama interferon (ifng), seqência de nucleotìdeos, vetor de expressão, célula hospedeira de glicosilação, população de variantes de polipeptìdeo com ifng ou de uma composição, composição farmacêutica, uso de uma variante de polipeptìdeo, e, métodos para o tratamento de doenças pulmonares intersticiais, para aumentar o grau de n-glicosilação in vivo de um polipeptìdeo com ifng parental, e para a produção de uma variante de polipeptìdeo com ifng | |
| JP4809352B2 (ja) | 線維芽細胞成長因子２１の突然変異タンパク質 | |
| ES2365000T3 (es) | Nuevas composiciones químicamente modificadas de proteína que estimulan eritropoyetina y métodos. | |
| RU2324494C2 (ru) | Новое применение эритропоэтина при сердечных заболеваниях | |
| TWI327068B (en) | L-methionine as a stabilizer for nesp/epo in hsa-free formulations | |
| ES2255713T3 (es) | Factor neurotrofico que se deriva de lineas celulares truncadas gliales. | |
| JPH08510998A (ja) | 呼吸道内の病理学的ムコイド気道内容物の粘度を低下させる方法 | |
| DK2640411T3 (en) | INTERLEUKIN-2 FOR SUBLINGUAL ADMINISTRATION TO USE IN TREATMENT OF INFLAMMATION | |
| CA2602914A1 (en) | Statherin peptide and use in medicine | |
| KR20050072743A (ko) | 점액 또는 타액의 액화를 위한 생성물 및 방법 | |
| US20130053313A1 (en) | New formulation for increasing bioavailability of neurturin | |
| JP3860415B2 (ja) | 骨代謝異常症治療剤 | |
| ES2421151T3 (es) | Adiponectina para el tratamiento de una neumopatía | |
| ES2216134T3 (es) | Utilizaciones del factor de crecimiento de los queratinocitos 2)(kgf-2). | |
| JPH08198772A (ja) | 顆粒球コロニー刺激因子含有粉末経鼻投与製剤 | |
| RU2002115633A (ru) | Конъюгаты интерферона | |
| US20040180835A1 (en) | Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock | |
| JPH107586A (ja) | インスリン様作用に起因する疾患の予防および／または治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |